Drag a card by its title · ⚙ to size, swap or remove

The company

Neurocrine Biosciences, Inc.

NBIX · Nasdaq

Health CarePharmaceuticalsNot moving yet

NBIX stood above a rising 150-day average in 28 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 6.4% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 32% -10 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $146.0M
Officials’ trades on record: 5
Institutions holding: 726 (+73)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.

21 Apr – 20 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

5 disclosed lines: House 5, Senate 0, executive 0; 3 people.

Who	Did	Amount	Traded
Lisa C. McClain House: U.S. House ClerkMI09	soldspouse	$1k–$15k	17 Jun 2025filed 13 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09	boughtspouse	$1k–$15k	11 Jun 2025filed 13 Aug 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39	bought	$1k–$15k	21 Dec 2020filed 11 Jan 2021
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39	sold	$1k–$15k	21 Jul 2020filed 19 Aug 2020
Josh Gottheimer House: U.S. House ClerkNJ05	sold	$1k–$15k	13 Dec 2018filed 4 Jan 2019

Insiders

Buy orders, 12 months0

Sale orders, 12 months30

Buyers · sellers0 · 15

Who	Did	Shares	Traded
Matt AbernethyChief Financial Officer	sold	2,311at $157.20	14 Sep 2026filed 15 Sep 2026
David W. BoyerChief Corp. Affairs Officer	sold	826at $157.45	14 Sep 2026filed 15 Sep 2026
Eric BenevichChief Commercial Officer	sold	2,154at $154.61	9 Sep 2026filed 10 Sep 2026
Leslie V. NorwalkDirector	sold	1,250at $182.01	28 Jul 2026filed 30 Jul 2026
Ingrid DelaetChief Regulatory Officer	sold	4,367at $181.02	10 Jul 2026filed 13 Jul 2026
Darin LippoldtChief Legal Officer	sold	10,000at $179.60	9 Jul 2026filed 13 Jul 2026
Ingrid DelaetChief Regulatory Officer	sold	8,433at $178.72	9 Jul 2026filed 9 Jul 2026
Ingrid DelaetChief Regulatory Officer	sold	2,737at $178.54	8 Jul 2026filed 9 Jul 2026
Ingrid DelaetChief Regulatory Officer	sold	3,401at $178.57	7 Jul 2026filed 9 Jul 2026
Darin LippoldtChief Legal Officer	sold	8,110at $170.03	29 Jun 2026filed 30 Jun 2026
Darin LippoldtChief Legal Officer	sold	1,690at $170.81	29 Jun 2026filed 30 Jun 2026
Darin LippoldtChief Legal Officer	sold	200at $169.57	26 Jun 2026filed 30 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders726+73 on the quarter

New · exited143 · 70

Reported value$16.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	13,711,607$2.3B	+326,000+2.4%
JPMORGAN CHASE & COnew · filed 12 Aug 2026	6,398,674$1.1B	+6,398,674
Dodge & Coxadded · filed 13 Aug 2026	5,584,707$941.2M	+123,670+2.3%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	4,974,083$838.3M	+247,739+5.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,545,339$766.0M	+33,435+0.7%
STATE STREET CORPadded · filed 7 Aug 2026	4,385,598$739.1M	+31,072+0.7%
AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026	3,818,037$643.5M	-1,120,930−22.7%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026	2,335,897$393.7M	-83,000−3.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,138,777$359.6M	+2,105+0.1%
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026	2,076,260$349.9M	-984,310−32.2%